Answers are grounded in this paper and cite their sources.
Hidradenocarcinoma (HAC) is an exceedingly rare and aggressive malignant tumor of the adnexal eccrine and apocrine sweat gland. Due to its low incidence rate, nonspecific clinical presentation, and similar histopathological features to benign hidradenoma (HA), HAC is often misdiagnosed as its benign counterpart.
No takes yet. Share an insight, caveat, or question.
Jenna et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: